S. 2691 · 115th Congress
Opioid Crisis Accountability Act of 2018
- Stage
- In committee
- Sponsor
- Bernie Sanders
- Introduced
- 2018-04-17
- Latest action
- 2018-04-17 · Introduced in Senate
Summary
Opioid Crisis Accountability Act of 2018
This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit a drug manufacturer from engaging in illegal marketing and distribution practices, including falsely advertising, promoting, or marketing that an opioid has no addiction-forming or addiction-sustaining qualities or risks.
The bill penalizes drug manufacturers or distributors who illegally advertise, market or distribute an opioid product, including by (1) imposing a civil fine or salary confiscation, (2)revoking any remaining period of market exclusivity for such product, (3)requiring reimbursement of federal funding received for such product, and (4)prohibiting certain tax credits.